H. D. Smith becomes primary supplier of pharmaceutical products for NAPPSA pharmacies

NewsGuard 100/100 Score

NAPPSA, a pharmacy buying group advancing the growing buying power of the Nigerian-owned independent retailers, today announced a new three-year prime vendor agreement with H. D. Smith, a leading national pharmaceutical wholesaler.

"This agreement, together with the programs and services available to our members through H. D. Smith, represents a significant accomplishment in the growth and identity of our organization," said Emmanuel Ezirim, owner of Central Point Pharmacy in Columbus, Ohio.  "In addition, the new prime vendor agreement will reduce the purchasing cost of our brand and generic pharmaceutical products, enabling us to compete with the large chains on a more level playing field."

"The decision to select a 'Primary Vendor' does not come lightly and demands close inspection of services, programs and reputation," said Dale Smith, chairman and chief executive officer, H. D. Smith.  "H. D. Smith strives continually to anticipate and meet the needs of independent retail pharmacies with a range of business solutions enabling retailers to adapt to the ever-changing marketplace.  We seek to enhance NAPPSA members' success."

Under the terms of the prime vendor agreement, H. D. Smith will become the primary supplier of pharmaceutical products for NAPPSA pharmacies, totaling more than 100 across the United States, beginning immediately, through June 30, 2013. "We are excited and proud of this accomplishment, and hope it is only the beginning of more to come. Since success breeds success, we anticipate more Nigerian-owned pharmacies to join or partner with NAPPSA," said Nnodum Iheme, president, NAPPSA.  

Source:

H. D. Smith; NAPPSA

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New urine-based test improves identification of high-grade prostate cancer